International Journal of Biological Engineering

International Journal of Biological Engineering is an international peer-reviewed multidisciplinary journal publishing original scientific research in all fields of biological pharmacy. Original research work that contributes significantly to further the scientific knowledge in biological pharmacy will be appreciated.

Zeev Blumenfeld

Editorial Board Member of International Journal of Biological Engineering

Associate Professor, Rambam Health Care Campus. Rappaport institute, Technion-Faculty of Medicine, Israel

Research Areas

Fertility Preservation Despite Chemotherapy, Reproductive Endocrinology, Infertility, Assisted Reproductive Technology-ART, IVF, Premature Ovarian Failure


1976M.D.Hebrew University and Hadassah Medical School, Jerusalem


1994-presentAssociate Professor of Obstetrics & Gynecology, Faculty of Medicine, Technion
1990-1994Senior Lecturer, Technion
1969-1973Research and teaching assistant at the Department of Anatomy and Embryology; Hebrew University and Hadassah Medical School (Teaching anatomy, embryology, and neuroanatomy)
1973-1974Associate teaching fellow in the Department of Anatomy and Morphologic Sciences, Technion

Academic Achievement

1970-1973-Maurberger prize [for four years]-excellence in medical studies, Hebrew University, Jerusalem
1988-Received the Polishuk award for the research: "Luteal Dysfunction in Ovulation Induction-The Role of Repetitive Human Chorionic Gonadotropin Supplementation during the Luteal Phase"-The annual meeting of the Israeli Society for Reproduction Research
1991-The Zondek Prize for the best abstract 1990-91, the annual meeting of the Israeli Endocrine Society (IES), 1991: "Growth hormone-binding protein (GH-BP) correlation with estrogen, progesterone, and gonadotropins in human: The effect of ovulation indu
1992-Prize of the Israel Fertility Society for the research "Growth Hormone-Binding Protein regulation in preovulatory follicles: Correlation with serum GH-BP levels"
2010-The best clinical poster Prize, the 39th annual meeting of the Israeli Endocrine Society (IES):"The protective effect of GnRH-a against chemotherapy associated gonadal failure in stem cell transplantation"
2011-Prize poster, the annual meeting of the Society for Gynecologic investigation (SGI), Miami beach, Florida, US: "The protective effect of GnRH-a against chemotherapy associated gonadal failure in stem cell transplantation"


Society for Gynecologic Investigation (Membership # 462-114)
The Endocrine Society, (Membership #138759) Membership
New York Academy of Sciences (Membership #336939)
American Society for Reproductive Medicine (former-American Fertility Society)
European Society of Human Reproduction and Embryology
Member of the executive committee of ESHRE [European Society of Human Reproduction & Embryology] task force of "Fertility Preservation in Severe Diseases"
Reproductive Biology Professional Group
International Society of Gynecological Endocrinology
Member of Research Board of Advisors (ABI)
Member of Board of Advisors (Fertile Hope)
Member of International Society of Fertility Preservation
Israeli Endocrine Society. Member of the executive council (2008-present)
Israeli Society for Fertility Research-member of directory council (1991-1995)

Publications: Journals

[1]  Makler A, Blumenfeld Z, Brandes JM, Paldi E: Factors affecting sperm motility. Human sperm velocity and percentage of motility as influenced by semen dilution. Fertil Steril 1979; 32: 442.
[2]  Makler A, Blumenfeld Z: Optimum measurements time for human sperm velocity determination. Arch Androl 1980; 5:89-194.
[3]  Makler A, Blumenfeld Z, David R, Better OS: Factors affecting sperm motility: VII-sperm motility as affected by change of pH and osmolarity of semen and urine specimens. Fertil Steril 1981; 36:507.
[4]  Blumenfeld Z, Kerner H, Thaler I, Deutsch M, Beck D: Increased alpha fetoprotein levels in mixed mesodermal tumors of ovary. Gynecol and Obstet Invest 1984;17:169-173.
[5]  Blumenfeld Z, Makler A, Gershon H, Brandes JM: An improved sperm immobilization test based on multiple exposure photography technique. Am J Reprod Immunol and Microbiol 1985; 7:27-31.
[6]  Blumenfeld Z, Kuhn RW, Jaffe RB: Corticotropin-releasing factor can stimulate gonadotropin secretion by human fetal pituitaries in superfusion. Am J Obstet Gynecol 1986; 154: 606-12.
[7]  Blumenfeld Z, Jaffe RB: Hypophysiotropic and neuroregulatory modulation of ACTH secretion by human fetal pituitary. J Clin Investig 1986;78: 288-94.
[8]  Monroe SE, Blumenfeld Z, Andreyko JL, Schriock E, Henzl MR, Jaffe RB: Dose-Dependent Inhibition of Pituitary-Ovarian Function during Administration of a GnRH Agonistic Analog (Nafarelin). J Clin Endocrinol Metabolism 1986; 63:1334-41.
[9]  Blumenfeld Z, Gershon H, Makler A, Stoler J, Brandes JM: Detection of antisperm antibodies: A cytotoxicity immobilization test. Int J Fertil 1986; 31:207-12. 1987 Reviewed and republished in "International Synopses".
[10]  Mulchahey J, DiBlasio AM, Martin CM, Blumenfeld Z, Jaffe RB: Hormone production and peptide regulation of the human fetal pituitary gland. Endocrine Reviews 1987;8: 406-22.
[11]  Jaffe RB, Mulchahey JJ, DiBlasio AM, Martin C, Blumenfeld Z, Dumesic DA: Peptide regulation of pituitary and target tissue function and growth in the primate fetus. Proceedings of the Laurenthian Hormone Conference. Recent Progress in Hormone Research, 1988; 44: 431-59.
[12]  Jaffe RB, DiBlasio AM, Blumenfeld Z, Martin MC, Seron-Ferre M: Neuroendocrine regulation of hormonal function and growth in the primate fetal hypothalamic-pituitary-adrenal system. Perinatal Press, 1989.
[13]  Nahhas F, Blumenfeld Z: The zona-free hamster egg penetration assay: Prognostic indicator in IVF program. Archives of Andrology 1989; 23:33-7.
[14]  Blumenfeld Z, Tapanainen P, Kaplan S, Grumbach M, Jaffe RB: Partial loss of responsiveness of human fetal pituitary cells to hGHRH after chronic exposure.Acta Endocrinologica1989;121:721-6.
[15]  Blumenfeld Z, Weiner Z, Lorber M, Sujov P, Thaler I: Anticardiolipin antibodies in patients with recurrent pregnancy wastage: Treatment and uterine blood flow. Obstet Gynecol 1991;78: 584-9.
[16]  Blumenfeld Z, Amit T, Barkey RJ, Lunenfeld B, Brandes JM: The synergistic effect of growth hormone and gonadotropins in achievement of conceptions in "clonidine negative" patients with unexplained infertility. New York Academy of Sciences 1991; 626:250-66.
[17]  Makler A, Makler-Shiran E, Stoler J, Lissak A, Abramovici H, Blumenfeld Z: Use of a sealed mini-chamber to investigate human sperm motility under aerobic and unaerobic conditions. Archives of Andrology 1992;29:255-61.
[18]  Blumenfeld Z, Barkey RJ, Youdim MBH, Brandes JM, Amit T: Growth hormone-binding protein regulation by estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction with menopausal gonadotropins, GH and gestation. J Clin Endocrinol Metabol 1992; 75:1242-9.
[19]  Makler A, Reiss J, Stoler J, Blumenfeld Z, Brandes JM: Use of a sealed mini-chamber for direct observation and evaluation of the in-vitro effect of cigarette smoke on sperm motility. Fertil Steril 1993; 59:645-51.
[20]  Blumenfeld Z, Halachmi S, Pertz B, Shmuel Z, Golan D, Makler A,Brandes JM: Premature ovarian failure-The prognostic application of autoimmunity on conception after ovulation induction. Fertility and Sterility 1993; 59:750-5.
[21]  Amit T, Dirnfeld M, Barkey RJ, Peleg I, Abramovici H, Hacham H, Blumenfeld Z: Growth hormone-binding protein (GH-BP) levels in follicular fluid from human preovulatory follicles: Correlation with serum GH-BP levels. J Clin Endocrinol Metabol 1993;77:33-9.
[22]  Blumenfeld Z, Amit T: The role of GH in ovulation induction.Annals of Medicine1994;9:209-13.
[23]  Blumenfeld Z, Dirnfeld M, Gonen Y, Abramovici H, Brandes JM: Growth hormone cotreatment for ovulation induction may enhance conception in the cotreatment and in the succeeding cycles, in clonidine negative but not in clonidine positive patients. Human Reproduction 1994; 94:209-13.
[24]  Makler A, Yoffe N, Reichler A, Stoler J, Blumenfeld Z: Inability of human sperm to change their orientation in response to external chemical stimuli. Fertil Steril 1995; 63:1077-82.
[25]  Shiran E, Stoller J, Blumenfeld Z, Feigin FD, Makler A: Evaluation of the accuracy of different counting chambers using strict counts of photographed beads. J Assist. Reprod and Genetics 1995; 12: 434-42.
[26]  Blumenfeld Z, Amit T: The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction. Journal of Pediat Endocrinol Metabol 1996; 9:145-62.
[27]  Avivi I, Polak S, Gideoni O, Linn S, Blumenfeld Z: Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: Correlation of corticotropin test and human leukocyte antigen typing. Fertil Steril 1996; 66:557-63.
[28]  Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N: Prevention of irreversible chemotherapy-induced ovarian damange in young women with lymphoma by a gonadotropin-releasing hormone agonist in parallel to chemotherapy. Human Reproduction 1996; 11:1620-6. Selected and discussed in the Year Book of Hematology, 1998.
[29]  Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z: Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematology 1997; 97:551-4.
[30]  Brenner B, Blumenfeld Z: Thrombophilia and fetal loss. Blood reviews 1997; 1:72-79.
[31]  Blumenfeld Z, Haim N: Prevention of gonadal damage during cytotoxic therapy. Annals of Medicine 1997; 29:199-206.
[32]  Jabareen A. Blumenfeld Z. Younis J, Lanir N, Brenner B: Prevention of recurrent fetal loss and gestational thromboembolism by enoxaparine. Thromb. Haemostasis 1997 suppl: 783.
[33]  Ornoy A, Yacobi S, Avraham S, Blumenfeld Z: The effect of sera from women with systemic lupus erythematosus and/or antiphospholipid syndrome on rat embryos in culture. Reproductive Toxicology 1998; 12:185-91.
[34]  Blumenfeld Z, Ritter M, Shen-Or Z, Shariki K, Ben-Shahar M, Haim N: Inhibin-A concentrations in the sera of young women during and after chemotherapy for lymphoma: Correlation with ovarian toxicity. Am. J. Reprod Immunol 1998; 39:33-40.
[35]  Krause I, Blumenfeld Z, Malchinsky M, Cohen S, Blank M, Eldor A. Weksler B, Schweitzer K, Shoenfeld Y: Anti-endothelial cell antibodies in the sera of hyperprolactinemic women. Lupus, 1998; 7:377-82.
[36]  Brenner B, Sarig G. Weiner Z, Younis J, Blumenfeld Z., Lanir N: Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Throm Haemost 1999; 82:6-9.
[37]  Sun QY, Blumenfeld Z, Rubinstein S, Goldman S, Gonen Y, Breitbart H: Mitogen-activated protein kinase in human eggs. Zygote, 1999; 7:181-5.
[38]  Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest 1999; 6:229-39.
[39]  A,B,C,D-Blumenfeld Z, Brenner B: Thrombophilia associated pregnancy wastage. Fertil Steril 1999; 72:765-774. Selected for: "Continued Medical Education" section of Fertility and Sterility.
[40]  A,B,C,D-Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with SLE treated by chemotherapy. Lupus 2000; 9:401-5
[41]  A,C,D-Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis J. Enoxaparin improves gestational outcome in thrombophilic women with recurrent pregnancy loss. Throm Haemost 2000. ; 83:693-7.
[42]  A,B,D-Yacobi S, Ornoy A, Blumenfeld Z. Miller RK: The effect of sera from women with systemic lupus erythematosus (SLE) and recurrent abortions on the proliferation and death of human trophoblastic cells in culture. Placenta 2000; 21:A37.
[43]  A,B,C,D-Blumenfeld Z.: Ovarian rescue/protection from chemotherapeutic agents. J Soc.Gynecol Invest 2001; 8: S60-64.
[44]  A,B,C,D-Blumenfeld Z and Ritter M,: Inhibin, Activin, and Follistatin in Human Fetal Pituitary and Gonadal Physiology. Ann.N.Y.Acad.Sci. 2001; 943:34-48
[45]  A,B,C,D-Blumenfeld Z. Response of human fetal pituitary cells to activin, inhibin, hypophysiotropic and neuroregulatory factors in vitro. Early Pregnancy, 2001; 5:41-2.
[46]  A,D-Sarig G, Younis J, Hoffman R Lanir N, Blumenfeld Z. Brenner B, Thrombophilia is common in women with pregnancy loss and is associated with late pregnancy wastage. Fertil Steril, 2002; 77: 342-7.
[47]  A,B,C,D-Blumenfeld Z.: Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and-B as markers. Molecular Cellular Endocrinology. 2002; 187:93-105.
[48]  A,B,C,D-Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe J.M: Fertility after treatment for Hodgkin's disease. Annals of Oncology. 2002; 13[Suppl.] 1:138-47.
[49]  A,B,D-Yacobi S, Ornoy A, Blumenfeld Z, Miller R. K.: The effect of sera from women with Systemic Lupus Erythematosus or Antiphospholipid Syndrome and recurrent abortions on human placental explants in culture. Teratology. 2002; 66: 300-8.
[50]  A,B,C,D-Blumenfeld Z. Review-Fertility after chemotherapy. Hungarian J. of Gynecologic Oncology. 2002; 7:27-40.
[51]  A,B-Matalon ST, Shoenfeld Y, Blank M, Yacobi S, Blumenfeld Z, Ornoy A.: The effects of IgG purified from women with SLE and associated pregnancy loss on rat embryos in culture. Am. J. Reprod. Immunol.2002; 48: 296-304.
[52]  A,B-Ornoy A, Yacobi S, Matalon ST, Blank M, Blumenfeld Z, Miller RK, Shoenfeld Y. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus. 2003; 12: 573-8.
[53]  A,B,C,D-Blumenfeld Z.: Hormonal suppressive therapy for endometriosis may not improve patient health. Fertility and Sterility. 2004; 81: 487-92.
[54]  A,B,C,D-Boulman N, Levy Y, Leiba R, Schachar S, Linn R, Zinder O, Blumenfeld Z: Increased C-Reactive Protein levels in the PCOS-a marker of cardiovascular disease. J Clin Endocrinol Metabol. 2004; 89:2160-65. Endocrine Society-Release to the Press 5.2004. Increased risk of CVD shown in PCOS patients. Cardiovascular Drug News, May 2004; 49: 26-7.
[55]  A,B,C,D-Blumenfeld Z, Eckman A. Preservation of Fertility and Ovarian Function and Minimizing. Chemotherapy Induced Gonadotoxicity in Young Women by GnRH-A. J.National Cancer Institute Monogr. 2005; 34:40-3.
[56]  A,C,D-Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Blumenfeld Z. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases. J Neurochem. 2007; 103: 962-71.
[57]  A,C,D-Rosenberg N, Soudry M, Rosenberg O, Blumenfeld I, Blumenfeld Z. The Role of Activin A in The Human Osteoblast Cell Cycle: A Preliminary Experimental in Vitro Study. Exp Clin Endocrinol Diabetes. 2010; 118:708-12. CLINICAL
[58]  Weisz GM, Blumenfeld Z, Barzilai A: Electrocardiographic changes in traumatized patients. J. American College of Emergency Physicians and the Univ. Ass. for Emergency Med. Services. 1976; 5:329-31.
[59]  Blumenfeld Z, Makler A, Zimmer E, Peer E, Brandes JM: Treatment of hirsutism with Cyproterone Acetate (Androcur). Harefuah 1980; 99:303.
[60]  Blumenfeld Z, Brandes JM, and Timor-Tritsch IE: Pregnancy and extrahepatic portal hypertension. Harefuah 1980; 98:116.
[61]  Dickstein G, Blumenfeld Z, and Barzilai D: The diagnosis and therpeutic approach in Cushing Syndrome-A critical review. Harefuah 1980; 98:268.
[62]  Makler A, Blumenfeld Z, Zimmer E: Evaluating the treatment of the hirsutic women and acne with cyproterone acetate (Hebrew). Harefuah 1980; 99:303-306.
[63]  Kerner N, Blumenfeld Z, Friedman M, Peretz BA, Brandes JM: Brenner tumors-A clinicopathologic study of benign, borderline and malignant types. J Obstet Gynecol 1981; 1:251.
[64]  Aviram M, Blumenfeld Z, Brook J, Lavi A: High-density lipoproteins subfractions in cord blood. Singapore J Obstet Gynecol 1982; 13:107-114.
[65]  Blumenfeld Z, Toledano C, Eitan A, Barzilai A, Brandes JM: Tubo-ovarian abscess in the postmenopausal women. World J Surg 1982; 6:634-636.
[66]  Naor N, Blumenfeld Z, Merzbach D, Timor-Tritsch IE, Seltzer M: Prevalence of group B streptococci in parturient mothers and their infants. Eur J Pediatr 1982; 138:166-7.
[67]  Makler A, Jakobi P, Deutsch M, Blumenfeld Z: Homologous intra uterine insemination with centrifugated sperm resuspended within umbilical cord serum. Harefuah 1982; 102:137.
[68]  Blumenfeld Z, Brook JG, Aviram M, Brandes JM: Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in perimenopausal women. Maturitas 1983; 5:77-83.
[69]  Brandes JM, Blumenfeld Z, Beck D, Eshkol A, Levithan E: Correlation of computed α fetoprotein clearance with actual clearance in a case of endodermal sinus tumour. J Obstet Gynecol 1984; 4:261.
[70]  Blumenfeld Z, Kerner H, Thaler I, Deutsch M, Beck D: Increased alpha fetoprotein levels in mixed mesodermal tumors of ovary. Gynecol and Obstet Invest 1984; 17:169-173.
[71]  Thaler I, Timor-Tritsch IE, Blumenfeld Z: Effect of acute hypoxemia on the human fetal heart rate-the significance of increased heart rate variability. Acta Obstet Gynecol Scandinavica 1985; 64:47-51.
[72]  Blumenfeld Z, Kerner H, Makler A, Eshkol A, Brandes JM: Clinical endocrine and ultrastructural study of XY-gonadal dysgenesis. J Reprod Med 1985; 30:211.
[73]  Blumenfeld Z: Clinical uses of Gonadotropin-releasing hormone (GnRH) and its analogues. BAKI-Clinical Biochemistry 1986; 5:170.
[74]  Edoute Y, Blumenfeld Z, Aharoni L, and Moskowitz M: Peripartum congestive cardiomyopathy and endocardial fibroelastosis associated with ritodrine treatment. J Reprod Medicine 1987; 23,10: 793-797.
[75]  Andreyko JL, Blumenfeld Z, Marshall LA, Monroe SE, Hricak H, Jaffe RB: Use of an agonistic analog of Gonadotropin-releasing hormone (Nafarelin) to treat Leiomyomata: assessment by magnetic resonance imaging. Am J Obstet Gynecol 1988; 158:903-910.
[76]  Blumenfeld Z, Makler A, Frisch L, Brandes JM: Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Gynecological Endocrinology 1988; 2:151-164.
[77]  Blumenfeld Z, Nahhas F: Luteal dysfunction in ovulation induction-the role of repetitive human chorionic gonadotropin supplementation during the luteal phase. Fertil Steril 1988; 50:403.
[78]  Blumenfeld Z, Frisch L, Conn PM: Gonadotropin-releasing hormone (GnRH) antibodies formation in hypogonadotropic azoospermic men treated with pulsatile GnRH-Diagnosis and possible alternative treatment. Fertil Steril 1988; 50:4. Discussed in the 1990 Yearbook of Infertility, Mosby Yearbook, Inc.
[79]  Blumenfeld Z, Nahhas F: Pretreatment of sperm with human follicular fluid (hFF) for borderline male infertility. Fertil Steril 1989; 51:863-868.
[80]  Blumenfeld Z, Thaler I, Gilhar A: Mode of delivery in Ehler-Danlos syndrome-A reappraisal of the current status. Int J Dermatology 1989; 28:621-623.
[81]  Blumenfeld Z, Lunenfeld B: The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient. Fertil Steril 1989; 52:328-331.
[82]  Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z: First and early second trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: Diverse prognosis of the septated from the non-septated lesion. American Journal of Obstetrics and Gynecology, 1989; 161:78-82. Discussed in the 1991 Yearbook of Obstetric Gynecology, p. 160.
[83]  Bronshtein M, Yoffe N, Brandes JM, Blumenfeld Z: First and early second trimester diagnosis of fetal urinary tract anomalies using transvaginal sonography. Prenatal Diagnosis 1990; 10:653-666.
[84]  Yoffe N, Blumenfeld Z: Gestation and spontaneous delivery in an hydrocephalic patient with ventriculo-peritoneal shunt. Harefuah 1990; 118:209-210.
[85]  Bronshtein M, Rottem S, Yoffe N, Blumenfeld Z, Brandes JM. Early determination of fetal sex using transvaginal sonography: Technique and pitfalls. J Clin Ultrasound 1990; 18:302-306.
[86]  Bronshtein M, Yoffe N, Blumenfeld Z, and Brandes JM: The hair as a sonographic marker of ovarian teratomas-Improved identification by using transvaginal sonography and simulating model. J Clin Ultrasound 1991; 19:351-355.
[87]  Blumenfeld Z, Yoffe N, and Bronshtein M: Transvaginal sonography in infertility and reproductive endocrinology. Obstet Gynecol Survey 1991; 46:36-49.
[88]  Bronshtein M, Zimmer E, Gershoni-Baruch R, Yoffe N, Meyer, Blumenfeld Z: First and second trimester diagnosis of fetal ocular defects and associated anomalies: Report of eight cases. Obstet Gynecol 1991; 77:443-449.
[89]  Yoffe N, Bronshtein M, Brandes JM, Blumenfeld Z: Hemorrhagic ovarian cyst detection by transvaginal sonography: The great imitator. Gynecological Endocrinology 1991;5:123.
[90]  Bronshtein M, Mashiah N, Blumenfeld I, and Blumenfeld Z: Pseudoprognathism-An auxiliary sonographic sign for transvaginal sonographic diagnosis of cleft lip and palate in the early second trimester. Am J Obstet Gynecol 1991; 165:1314-1316.Surveyed and republished in Search on Obstet Gynecol 1992; 1:17-19 (Italian).
[91]  Brenner B, Blumenfeld Z, Markiewicz W, and Reisner SA: Cardiac involvement in patients with primary antiphospholipid syndrome. Journal of American College of Cardiology 1991;18: 931-936.
[92]  Blumenfeld Z: Growth hormone-A cogonadotropin? Its role in ovulation induction. Journal of In-Vitro Fertilization and Embryo Transfer 1991; 8:127-136.
[93]  Bronshtein M, Blumenfeld Z. First-and early second-trimester oligohydramnios-A predictor of poor fetal outcome except in iatrogenic olygohydramnios post chorionic villi biopsy. Ultrasound in Obstetrics and Gynecology 1991; 1(4): 245-249.
[94]  Bronshtein M, Lieberson A, Lieberson S, Blumenfeld Z: Clubfeet associated with hydrocephalus-New evidence of gradual dynamic development in utero. Obstet Gynecol 1992; 79(suppl): 864-867.
[95]  Bronshtein M, Blumenfeld Z: Transvaginal Sonography-Detection of findings suggestive of fetal chromosomal anomalies by transvaginal sonography in the first and early second trimester. Prenatal Diagnosis 1992; 12:587-593.
[96]  Blumenfeld Z, Dirnfeld M, Abramovici H, Amit A, Bronshetein M, Brandes JM: Spontaneous fetal reduction in multiple gestations assessed by transvaginal ultrasound Br J Obstet Gynaecol. 1992; 99:333-337.
[97]  Bronshtein M, Tzidony D, Dimant M, Hajos J, Jaeger M, Blumenfeld Z: Transvaginal sonographic measurements of the fetal adrenal glands at 12 to 17 weeks of gestation. Am J Obstet Gynecol 1993; 169:1205-1210.
[98]  Bronshtein M, Yoffe N, Zimmer E, and Blumenfeld Z: Early detection of fetal anomalies by transvaginal sonography. Fetal and Maternal Medicine Review 1993; 5:137-146.
[99]  Makler A, Stoler J, Blumenfeld Z, Feigin PD, Brandes JM: Investigation in real time the effect of gravitation on human spermatozoa and their tendency to swim up and to swim down. Int J Androl 1993;16:251-257.
[100]  Ruach M, Blumenfeld Z: Late onset congenital adrenal hyperplasia-The diversity of the various diagnostic methods. Harefuah 1993; 124:249-253.
[101]  Bronshtein M, Bar-Hava I, Blumenfeld I, Bejar J, Toder V, Blumenfeld Z: The difference between septated and non-septated nuchal cystic hygroma in the early second trimester. Obstet Gynecol 1993; 81:683-687.
[102]  Baruch Y, Weiner Z, Enat R, Ronen A, Blumenfeld Z: Pregnancy after liver transplantation. Int J Gynecol Obstet 1993; 41:273-276.
[103]  Bronshtein M, Weiner Z, Abramovici H, Filmar S, Erlik Y, Blumenfeld Z: Second trimester diagnosis of fetal gallbladder anomalies by transvaginal sonography-Report of seventeen cases. Prenatal Diagnosis 1993; 13:851-861.
[104]  Blumenfeld Z, Siegler E, and Bronshtein M: The early diagnosis of neural tube defect. Prenatal Diagnosis 1993;13:863-871.
[105]  Bronshtein M, Bar-Hava I, and Blumenfeld Z: Differential diagnosis of the non-visualized fetal urinary bladder by transvaginal sonography in the early second trimester. Obstet Gynecol 1993;82:490-493.
[106]  Bronshtein M, Blumenfeld I, Cohen I, and Blumenfeld Z: Fetal ultrasonographic detection of hypodontia in the Neu-Laxova syndrome. J Clin Ultrasound 1993; 21:648-650.
[107]  Bronshtein M, Amit A, Achiron R, Noy I, Blumenfeld Z: The early prenatal sonographic diagnosis of renal agenesis: Technique and possible pitfalls. Prenatal Diagnosis 1994; 14:291-297.
[108]  Blumenfeld Z, Lorber M, Yoffe N, and Scharf Y: Systemic lupus erythematosus-a predisposition for uterine cervical dysplasia. Lupus 1994; 3:59-61.
[109]  Blumenfeld Z, Bentur L, Yoffe N, Alroy G, Rubin AR: Menstrual asthma-Use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril 1994; 62:197-200.
[110]  Blumenfeld Z: PCO-from basic science to clinical practice. European J Obstet Gynecol and Reprod Biol 1994; 55:29-30.
[111]  Bronshtein M, Blumenfeld I, Kohn J, and Blumenfeld Z: Detection of cleft lip and palate by early second trimester transvaginal sonography. Obstet Gynecol 1994; 84:73-76.
[112]  Blumenfeld Z, Lang N, Kahana L, and Yoffe N: Native GnRH for triggering follicular maturation in PCOS patients undergoing hMG ovulation induction. Fertil Steril 1994;62:456-460.
[113]  Abramovici H, Dirnfeld M, Auslander R, Bornshtein J, Blumenfeld Z, Sorokin Y: Pregnancies following treatment by GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine leiomyomata. Int J Fertility 1994; 39:150-155.
[114]  Makler A, Poppa E, Rosenberg B, Blumenfeld Z: Investigation in real-time of the effect of inhalational anesthetics on the motility of human spermatozoa. Isr J Obstet Gynecol 1995; 6:34-40.
[115]  Bronshtein M, Zimmer E, and Blumenfeld Z: Transvaginal sonography (TVS) of the fetal urinary tract. Ultrasonoor Bulletin 1995;19-23.
[116]  Blumenfeld Z, Zimmer E, Bronshtein M: The multidirectional sonographic approach to midtrimester elevated amniotic alpha-fetoprotein or positive acetyl cholinesterase: Transvaginal, transumbilical, and transabdominal. Obstet Gynecol 1995;86:565-568.
[117]  Bronshtein M, Zimmer EY, and Blumenfeld Z: Transvaginal sonography (TVS) of the fetal urinary tract. European Journal of Ultrasound 1996;3:1-7.
[118]  Avivi I, Blumenfeld I, Blumenfeld Z: The therapeutic potential of ozone-possible side effects. Harefuah 1996; Harefuah 1996; 130:327-330.
[119]  Bronshtein M., Blumenfeld I., Blumenfeld Z.: The early prenatal diagnosis of cleft lip and the decision making process for termination of pregnancy. Br J Oral. Maxillofacial Surgery 1996; 34:486-487.
[120]  Stahl S, Blumenfeld Z, Yarnitsky D: Carpal tunnel syndrome in pregnancy. Journal of Neurological Sciences 1996; 136:182-184.
[121]  Blumenfeld Z: The role of growth hormone (GH), GH-receptor and GH-binding protein in ovulation induction and ovarian physiology. Review Article. Isr J Obstet Gynecol 1996; 7:200-210.
[122]  Ullmann Y, Blumenfeld Z, Hakim M, Mahoul I, Sujov P, Peled I: Urgent delivery, the treatment of choice in term pregnant women with extended burn injury. Burns 1997; 23:157-159.
[123]  Blumenfeld Z, Shen-Or Z, Har'el H, Jacobson S, Ruach M, Ish-Shalom S, Zinder O: Corticotropin-releasing factor and adrenocorticotropin tests in chronic anovulatory women: Polycystic ovary syndrome, late onset congenital adrenal hyperplasia, and acanthosis-nigricans. Isr J Obstet Gynecol 1997; 8:158.
[124]  Assy N, Blumenfeld Z, Berkovitz D, Nave Y, Kramsky R, Rosenthal E, Enat E, Baruch Y: Long-term follow-up of liver transplant patients in a nonliver transplantation center. Transplantation Proceedings 1997; 29:2664-2666.
[125]  Bronshtein M, Blumenfeld I, Zimmer E, Ben-Ami M, Blumenfeld Z: Prenatal sonographic diagnosis of nasal malformations. Prenatal Diagnosis 1998;18: 447-454.
[126]  Blumenfeld Z, Shabadash V, Shen-Orr Z: Pathophysiology and origin of ascites in ovarian hyperstimulation syndrome. Assisted Reproduction Reviews 1998; 8:102-110.
[127]  Blumenfeld Z, Ritter M, Avivi I, Eibschitz I: Minimizing chemotherapy induced gonadotoxicity-the role of inhibin-a as a possible marker. Isr J Obstet Gynecol 1998; 9:108-119.
[128]  Blumenfeld Z, Amit A, Kerner H, Bronshtein M, Auslander R, Deutsch M: Ovarian calcifications detection by transvaginal sonography-a possible solitary marker of borderline ovarian malignancy. Israel J. Obstet. Gynecol. 1998; 9:276-279.
[129]  Blumenfeld Z, Blumenfeld I, Bronshtein M: The early prenatal diagonsis of cleft lip and the decision making process. Cleft Palate-Craniofacial Journal. 1999; 105-107.
[130]  Bronshtein M, Blumenfeld Z. Split thalami-possible auxiliary sonographic sign for the early diagnosis of agenesis of corpus callosum. Israel J Ob Gyn 1999; 10(2):55-58.
[131]  Blazer S, Zimmer EZ, Blumenfeld Z, Zelikovic I, Bronshtein M: Natural history of fetal simple renal cysts detected in early pregnancy. J Urol 1999; 162:812-814.
[132]  Dirnfeld M, Bider D, Abramovici H, Calderon I, Blumenfeld. Subsequent successful pregnancy and delivery after intracytoplasmic sperm injection in a patient with XY gonadal dysgenesism. Europ J Obstet Gynecol Reprod Biol 2000, 88:101-102.
[133]  Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus. 2000; 9(6):401-5.
[134]  Lobushitzky R, Levy M, Shen-Or Z, Blumenfeld Z Herer P, Lavie P, Long-term melatonin administration does not alter pituitary gonadal hormone secretion in normal adult men. Human Reprod 2000:15:60-65.
[135]  Blumenfeld Z. Hirsutism-evaluation and treatment. Isr Med Assoc J. 2000; 2:632-634.
[136]  A,B,C,D-Blumenfeld Z.: GnRH-Antagonists instead of agonists: Change a common practice for a better-not for merely a newer one. Fertility Sterility 2001: Vol 76:443-4.
[137]  A,D-Weiner Z, Younis J.S, Blumenfeld Z, Shalev E: Assessment of uterine placental circulation in thrombophilic women. Seminars in Thrombosis & Hemostasis. 2003; 29: 213-8.
[138]  A,B,C,D-Blumenfeld Z.Gynecologic Concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol. 2003 Oct; 15(5): 359-70.
[139]  A,D-De Schepper J, Schiettecatte J, Veldeniers B, Blumenfeld Z, Shteinberg M, Devroey P, Anckaert E, Smitz J, Verdoodt P, Hooghe R, Hooghe-Peters E: Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. Eur J Endocrinol. 2003 Sep; 149:201-7.
[140]  A,B,C,D-Quint EH, Breech L, Blumenfeld Z. Case 2005: ovarian suppression with chemotherapy in adolescents. J Pediatr Adolesc Gynecol. 2004 Dec; 17(6):413-6.
[141]  A,D-Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost. 2005 Feb;3(2):227-9.
[142]  A,C,D-Bronshtein M, Arad A, Solt I, Blumenfeld Z. Pilonidal Sinus-The Tale of the Fetal Tail. European Journal of Obstetrics& Gynecology& ReproductiveBiology.2005;119:255-6
[143]  A,B,C,D-Dann EJ, Epelbaum R, Haim N, Ben Shahar M, Rowe JM, Blumenfeld Z.: Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for Non Hodgkin Lymphoma.Human Reprod. 2005; Aug; 20(8):2247-9.
[144]  A,B,C,D-Blumenfeld Z, Eckman A. Tratamientos oncologicos y supervivencia folicular. Medicina Reproductiva 2005; 11:33-43.
[145]  A,B,C,D-Blumenfeld Z, Eckman A. Preservacion de la ferdilidad y la funccion ovarica y minimizacion de la gonadotoxicidad inducida por la quimiotherapia en mujeres jovenes. Medicina Reproductiva 2005; 11:57-76.
[146]  A,B,C,D-Blumenfeld Z, Eckman A.Preservation of Fertility by Gonadotropin-Releasing Hormone Agonists. GnRH-Agonisten und Ovarschutz. 2005; Der Gynäkologe; Suppl 1: S42-S51.
[147]  A,B,C,D-Blumenfeld Z-Invited Chapter Editor on:"Fertility Drugs, IVF and the risk of Gynaecologic Malignancies." Chapter Editor's Introduction-CME Journal of Gynecologic Oncology 2005; 9: 235-264.
[148]  A,B,C,D-Lowenstein L, Solt I, Blumenfeld Z-Invited Chapter Editor on ART and Gynecologic Cancer: Drawbacks of Assisted Reproductive Technology in the Offsprings: retinoblastoma, Beckwith-Wiedemann, and Angelman syndromes. CME Journal of Gynecologic Oncology 2005; 9: 253-5.
[149]  A,B,C,D-Blumenfeld Z-Invited Chapter Editor on ART and Gynecologic Cancer. Drawbacks of Assisted Reproductive Technology-Chapter Editor's Conclusions-CME Journal of Gynaecologic Oncology 2005; 9: 264.
[150]  A,D-Sarig, Z. Blumenfeld, R. Leiba, N. Lanir, B. Brenner. Modulation of Systemic Hemostatic Parameters by Low Molecular Weight Heparin during Gestation of women with Pregnancy Loss. Thromb Haemost. 2005 Nov; 94(5):980-5.
[151]  A,B,C,D-Blumenfeld Z, Lowenstein L, Brook O, Gonen R, Ophir E, Samueloff A. "Does Maternal Height Affect Triplets' Birth Weight?". Med Sci Monit. 2006 Jan;12(1):CR40-43. Epub 2005 Dec 19.
[152]  A,D-Elis A, Tevet A, Yerushalmi R, Blickstein D, Bairy O, Dann EJ, Blumenfeld Z, Abraham A, Manor Y, Shpilberg O, Lishner M. Fertility status among women treated for aggressive non-Hodgkin's lymphoma. Leukemia & Lymphoma 2006; 47:623-7.
[153]  A,D-Sarig G, Aberbach I, Schliamser L, Blumenfeld Z, Brenner B. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy. Thromb Haemost. 2006; 96: 578-83.
[154]  A,B,C,D-Blumenfeld Z, Boulman N, Leiba R, Siegler E, Shahar S, Linn R, Levy Y. High C-reactive protein Levels are associated with Oral Hormonal Menopausal Therapy but Not with Intrauterine Levonorgestrel and Transdermal Estradiol."The Scandinavian Journal of Clinical & Laboratory Investigation." 2007; 67:257-63.
[155]  A,B,C,D-Blumenfeld Z. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy. Minerva Endocrinol. 2007; 32:23-34. Review.
[156]  Blumenfeld Z., I. Avivi, Eckman, R. Epelbaum, J.M. Rowe, E.J. Dann. Gonadotropin Releasing Hormone Agonist Decreases Chemotherapy Induced Gonadotoxicity and Premature Ovarian Failure in Young Female Patients With Hodgkin Lymphoma. Fertil Steril. 2008 Jan;89(1):166-73. Epub 2007 Jun 28.
[157]  B,D-Sills ES, Qublan HS, Blumenfeld Z, Dizaj AV, Revel A, Coskun S, Jaoude IA, Serour G, Eskandar M, Khalili MA, Demirol A, Trokoudes K, Ocal P, Sultan AM, Lotto BA, El-Kareh A.Regional clinical practice patterns in reproductive endocrinology: A collaborative transnational pilot survey of in vitro fertilization programs in the Middle East. 1: J Exp Clin Assist Reprod. 2007 Aug 28;4(1):3 [Epub ahead of print].
[158]  A,B,C,D-Blumenfeld Z. Debate: How to preserve fertility in young women exposed to chemotherapy? The role of GnRH-agonist in addition to cryopreservation of embryos, oocytes, or ovaries. The Oncologist 2007; 12:1044-1054. Selected for CME-Continued Medical Education Manuscript.
[159]  A,B,C,D-Blumenfeld Z and von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Human reproduction Update;14:543-52.
[160]  A,B,C,D-Blumenfeld Z. Editorial—Recent Developments in Clinical Medicine: Reproductive Health. Clinical Medicine: Reproductive Health 2008:2 1-3. 14 Jul 2008
[161]  A,B,C,D-Blumenfeld Z. GnRH-agonists in fertility preservation. Current Opinion in Endocrinology, Diabetes, and Obesity. 2008 Dec; 15(6):523-8.
[162]  A,B,C,D-Blumenfeld Z, Abdallah W, Sela-Guttmann O, Brook OR. Triplet Gestation-Prevention, Risks, & Management Dilemmas. The Open Women' Health Journal, 2008, 2, 11-21.
[163]  A,B,C,D-Blumenfeld Z, Abdallah W, Kaplan D, Nevo O. Endometrial thickness-a practical prospective marker for the risk of surgical intervention after RU486 induced abortion. Clinical Medicine: Reproductive Health. 2008:2; 25-30.
[164]  A,B,C,D-Blumenfeld Z. Premature ovarian failure: etiology and possible prevention. Expert Review of Endocrinology & Metabolism 2009; 4:173-181.
[165]  C,D-Bronshtein M, Khatib N, Blumenfeld Z, Prenatal Diagnosis and Outcome of Isolated Interrupted Inferior Vena Cava. Amer. J. Obstet. Gynecology. Am. J. Obstet. Gynecol. 2010; 202:398.e1-4.
[166]  A,B,C,D-Blumenfeld Z, Zuckerman T. Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist. The Oncologist. 2010;15:59-60.
[167]  C,D-Younis, J, Shukha, M, Ben-Ami, M, Izhaki, I, Blumenfeld, Z, Brenner, B, Sarig G. Prospective Evaluation of the Protein C Global Assay during Pregnancy Following Assisted Reproduction. Obstet.Gynecol. 2010;115:969-74.
[168]  A,B,C,D-Blumenfeld Z. Fertility Treatment in Women with Premature Ovarian Failure. Expert Rev. Obstet. Gynecol. 2011; 6; 321-330.
[169]  Blumenfeld Z, Mischari O, Schultz N, Boulman N, Balbir-Gurman A. Gonadotropin Releasing Hormone Agonists May Minimize Cyclophosphamide associated Gonadotoxicity in SLE and Autoimmune Diseases. Semin Arthritis Rheum. 2011 Aug 23. [Epub ahead of print] 2011.
[170]  Moshe Bronshtein, Etan Z. Zimmer, Shraga Blazer, Zeev Blumenfeld. Right Ductus Arteriosus-Facts and Theory. Accepted, European J Ob Gyn & Reprod biology. 2011
[171]  E.J. Dann, Z. Blumenfeld, R. Bar-Shalom I. Avivi1, M. Ben-Shachar, O. Goor, D. Libster, J.M. Rowe, R. Epelbaum. For Standard and High-Risk Patients with Unfavorable Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based on Interim Scintigraphy, Are Efficacious and Female Fertility Is Preserved. Accepted-Am. J. Hematology.2011.

Publications: Books/Book Chapters

[1]  Blumenfeld Z, Rottem S, Elgali S, and Timor-Tritsch IE: Transvaginal assessment of early embryologic development. In: Transvaginal Sonography, eds. I.E. Timor-Tritsch, S. Rottem. Elsevier Science Publishing Company, Inc., 1988; pp. 87-108.
[2]  Timor-Tritsch IE, Rottem S, Blumenfeld Z: Pathology of the early intrauterine pregnancy. In: Transvaginal Sonography, eds. I.E. Timor-Tritsch, S. Rottem. Elsevier Science Publishing Company, Inc., 1988; pp. 109-124.
[3]  Drugan A, Blumenfeld Z, Erlik Y, Timor-Tritsch IE, Brandes JM: The use of transvaginal sonography in infertility. In: Transvaginal Sonography. Timor-Tritsch IE,Rottem S (eds.), Elsevier Science Publishing Company, Inc.,1988, pp.143-159.
[4]  Blumenfeld Z, Makler A, Frisch L, Brandes JM: Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile GnRH. Proceedings of the 1st Congress of the International Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988. Parthenon Press, New Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp.5-10.
[5]  Blumenfeld Z, Nahhas F: Luteal dysfunction in ovulation induction-the role of repetitive human chorionic gonadotropin supplementation during the luteal phase. Proceedings of the 1st Congress of the International Society of Gynecologic Endocrinology, Crans Montana, Switzerland, March 1-7, 1988. Parthenon Press, New-Jersey, USA. Edited by Genazzani AR, Petraglia F, Volpe A, Facchinetti F, 1988, pp. 329-333.
[6]  Blumenfeld Z, Dirnfeld M, Beck D, Abramovici H, Brandes JM: Comparison of treatment of uterine leiomyomata with 3 GnRH agonistic analogues-Efficacy and side effects. Proceedings of the International Symposium on GnRH Analogues in Cancer and Human Reproduction, Geneva, Switzerland, 1988, MTP Press, Lancester, 1989, pp. 45-52.
[7]  Blumenfeld Z, Lunenfeld B, Brandes JM: The permissive role of growth hormone in ovulation induction with human menopausal gonadotropin. In: Advances in Assisted Reproductive Technologies. Mashiach S, Ben-Rafael Z, Laufer N, Shenker J, eds. New-York: Plenum Press, 1990, pp. 397-408.
[8]  Timor-Tritsch IE, Blumenfeld Z, Rottem S: Sonoembryology. In: "Transvaginal Sonography", ed. Timor-Tritsch IE, Rottem S. 2nd ed. 1991. New-York: Elsevier, pp. 225-298.
[9]  Blumenfeld Z, Thaler I, Weiner Z, Beck D, Brandes JM: Treatment of uterine leiomyomata with GnRH analogue (Nafarelin): A clinical protocol of interrupted (on and off) treatment. In: "Advances in the Study of GnRH Analogues", Vol. 4-GnRH Analogues and Cancer, ed. B. Lunenfeld. Proceedings of the 2nd International Symposium on GnRH Analogues. London: Parthenon Publishing Group Limited, 1991; pp. 123-131.
[10]  Blumenfeld Z, Brandes JM, and Bronshtein M: Ultrasonography of abnormal early pregnancy. In: The First Twelve Weeks of Gestation, Heidelberg: Springer Verlag, 1992, pp. 358-375.
[11]  Abramovici H, Dirnfeld M, Auslander R, Sorokin Y, Blumenfeld Z: Pregnancies following treatment by GnRH-a (Decapeptyl) and myomectomy in infertile women with uterine leiomyomata. In: GnRH Analogues and Cancer, edited by B. Lunenfeld, Vol. 4, Parthenon Publishing Co., 1992, pp. 119-122.
[12]  Blumenfeld Z: Treatment of uterine leiomyomata by LH-RH agonists. In: K. Hoffken, ed., "Peptides in Oncology: LH-RH Agonists and Antagonists", Berlin: Springer Verlag, 1992, pp. 19-31.
[13]  Blumenfeld Z, Amit T: The Role of GH in Ovulation Induction. In: Molecular and Clinical Advances in Pituitary Disorders-1993. S. Melmed, ed., Proceedings of the 3rd International Pituitary Congress. Endocrine Research and Education, Inc., Los Angeles, CA. pp. 205-210, 1994.
[14]  Bronshtein M, Blumenfeld Z: Ultrasound and Down Syndrome In: J.G. Grudjinskas, T. Chard, M. Chapman and H. Cuckle (eds.), Screening for Down's Syndrome, Chapter 12, 1994, Cambridge University Press, pp. 181-193.
[15]  Bronshtein M, Zimmer E, Gershoni R, Yoffe N, Meyer H, Blumenfeld Z: First and second trimester fetal occular defects. In: S. Matsumoto, K. Sato, N. Tamaki, S. Oi (eds.), Annual Review of Hydrocephalus, Vol. 10, Neuron Publishing Co. Ltd., 1992, pp. 56-57.
[16]  Blumenfeld Z, Bronshtein M: Spontaneous embryo and fetal reduction and the early detection of fetal anomalies using transvaginal sonography. In: Implantation and Early Pregnancy in Humans, edited by ER Barnea, JH Check, JG Grudjinskas and T Marou, London: Parthenon Publishing Group, 1994, pp. 435-463.
[17]  Blumenfeld Z: New applications and indications for native gonadotropin-releasing hormone (GnRH) and for GnRH analogues (GnRH-a). In: Infertility and Transvaginal Sonography-Current Concepts, edited by S. Desai, G. Allahbadia, New Delhi: Jaypee Medical Publisher Ltd, 1995, pp. 47-54.
[18]  Zimmer EZ, Blumenfeld Z, Bronshtein M: The Fetal Eye. In: Ultrasonography of the Prenatal and Neonatal Brain, edited by: IE Timor-Tritsch, AC Monteagudo, H Cohen. Appleton and Lange. 1996, Chapter 10, pp. 333-346.
[19]  Bronshtein M, Blumenfeld Z: Spontaneous evolution of fetal malformations detected in the first trimester. In: Ultrasound in the First Trimester of Pregnancy, edited by E. Jauniaux, Barnea E, Edwards RG. Pp365-375. 1997.
[20]  Bronshtein M, Zimmer E, and Blumenfeld Z: Early midtrimester transvaginal sonography for the detection of chromosomal abnormalities. In: Transvaginal Sonography, edited by I.E. Timor-Tritsch and S. Rottem, edition 3, Chapman-Hall.
[21]  Blumenfeld Z, Bronshtein M: Detection of fetal dyskaryosis by midtrimester transvaginal sonography. In: Transvaginal Sonography in Infertility, 1998. Edited by G. Allahbadia, Rotunda Med. Technologies Pvt Ltd, Bombay, India pp 393-405.
[22]  Bronshtein M, Blumenfeld Z, and Zimmer E: Early detection of fetal malformations with transvaginal sonography. In: Transvaginal Sonography, edited by I.E. Timor-Tritsch and S. Rottem, edition 3, Chapman-Hall, 1998.
[23]  Bronshtein M, Zimmer EZ, and Blumenfeld Z: Early sonographic detection of fetal anomalies. In: Kurjak A (ed.), Textbook of Perinatal Medicine. Parthenon Publishing, 1998, Lancaster, UK, pp 263-281.
[24]  Blumenfeld Z, Shabadash V, Shen-Orr Z: The ovary as the origin of OHSS. In: "Pathophysiology of OHSS", Ed: A. Pellicer, C. Simon, F. Bonilla-Musoles, J. Remohi. Serono Symposia Publications, Vol. 4, 1999:69-88.
[25]  Blumenfeld Z: A rationalized treatment for OHSS. In: "Pathophysiology of OHSS", Ed: A. Pellicer, C. Simon, F. Bonilla-Musoles, J. Remohi. Serono Symposia Publications, Vol. 4, 1999:185-196.
[26]  Blumenfeld Z, Bronshtein M. Chromosomal abnormalities. In: Transvaginal sonography of the fetus in early pregnancy. Parthenon Publishing2000 p 195-209.
[27]  Blumenfeld Z, Zimmer E, Weizmanm B, Bronshtein M. Central nervous system.Chromosomal abnormalities. In: Transvaginal sonography of the fetus in early pregnancy. Parthenon Publishing, 2000 p 41-65.
[28]  Blumenfeld Z, Weizman B, Talmon R, Bronshtein M. The fetal urinary tract.. In: Transvaginal sonography of the fetus in early pregnancy. Parthenon Publishing. 2000 p 165-187.
[29]  Blumenfeld Z. Ovulation induction by gonadotropins. Chapter in book "Ovulation Induction", ed. Gautam Allahbadiah, Rotunda Press, Mumbay. India, 2000: 27-45.
[30]  Bronshten M, Z. Blumenfeld Valor de la ecografia transvaginal dirigidarealizada por un ecografista experto al inicio del segundo trimestre paradeteccion de malformaciones fetales. "Cuadernos De Medicina Reproductuve Editor: A. Pellicer, C. Simon V. Serra-Serra, Editorial Medica Panamercina Madrid 2001 p 103-120 Vol 7 No 1.
[31]  Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy-associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and-B as markers "Advances in Gynecological Endocrinology" Edited by A.R. Genazzani and F. Petraglia. Parthenon Publishing.
[32]  Blumenfeld Z. The Endocrinology of ART. In: The Art & Science of Assisted Reproductive Techniques (ART); Editors: Gautam Allahbadia & Rita Basuray. Jaypee Brothers Medical Publishers (P) Ltd. New Delhi. 2003. Pp: 6-14.
[33]  Blumenfeld Z. Ovarian Tissue Cryopreservation in Cancerous Patients: State of the Art. In: The Art & Science of Assisted Reproductive Techniques (ART); Editors: Gautam Allahbadia&Rita Basuray. Jaypee Brothers Med. Pub. New Delhi. 2003. Pp: 320-32.
[34]  Blumenfeld Z. The Patient with Systemic Lupus Erythematosus. In: IVF in the medically complicated patient: a guide to management. Ed. Nick S. Macklon. Taylor & Francis. London 2005. Pp: 51-60.
[35]  Blumenfeld Z. Quimoprevencion. In:"Preservacion de la fertilidad en la paciente oncologica", Editor: Justo Calejjo Olmos. Editorial glosa,S.L., ANGELINI. Barcelona, Spain. 2009. Pp:57-88.